Indaptus Therapeutics Inc

NASDAQ:INDP 3:59:51 PM EDT

3.13

+0.52 (+19.92%)

Products

Indaptus Therapeutics Announces FDA Clearance Of INDA To Initiate Phase 1 Clinical Trial Of DECOY20 In Solid Tumors

Published: 05/19/2022 11:07 GMT

INDP

Indaptus Therapeutics Inc (INDP) - Indaptus Therapeutics Announces FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Decoy20 in Solid Tumors.